BridgeBio Oncology (BBOT)

• Market cap: $894M
• 1 day: -2.78%
• 5 days: -15.88%
• 1 month: -5.65%
• 3 months: -1.93%
• 6 months: 4.68%
• Year to date: -9.03%
• 1 year: 5.47%
• 5 years: 9.72%
• 10 years: 9.72%
• Sector: Healthcare
• Industry: Biotechnology

About: BridgeBio Oncology Therapeutics Inc, formerly BridgeBio Oncology Therapeutics is a clinical-stage biotechnology company that aims to transform the lives of patients with cancers driven by RAS and PI3Ka, the two frequently mutated oncogenes.

Employees: 81